| Identification | Back Directory | [Name]
1,2-Benzenediamine, N1-[(S)-(3-chloro-2-pyridinyl)(2,2-difluoro-1,3-benzodioxol-4-yl)methyl]-N2-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-(methylsulfonyl)- | [CAS]
2565705-01-1 | [Synonyms]
1,2-Benzenediamine, N1-[(S)-(3-chloro-2-pyridinyl)(2,2-difluoro-1,3-benzodioxol-4-yl)methyl]-N2-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-(methylsulfonyl)- | [Molecular Formula]
C25H21ClF2N6O6S | [MOL File]
2565705-01-1.mol | [Molecular Weight]
606.99 |
| Hazard Information | Back Directory | [Uses]
Dot1L-IN-6 is a potent disruptor of telomeric silencing 1-like protein (DOT1L) inhibitor with an IC50 SPA DOT1L of 0.19 nM[1]. | [in vivo]
Dot1L-IN-6 (Compound 9) shows an excellent blood exposure after a single dose (100 mg/kg)[1]. | [References]
[1] Frédéric Stauffer, et al. New Potent DOT1L Inhibitors for in Vivo Evaluation in Mouse. ACS Med. Chem. Lett. 2019, 10, 12, 1655-1660. |
|
|